hotspot -WSS

hotspot

author：leisure time 2025-09-03 03:41:00 - browse：796

Illustration of two DNA strands made of banknotes. -- health coverage from STAT — Adobe

The staff of the Institute for Clinical and Economic Review, or ICER, are known as the nerds of the drug industry: bespectacled killjoys who emerge a few times a year to scold drugmakers for pricing their latest cancer or MS advance far beyond reason.

But last year, they sat down and concluded a forthcoming treatment was worth up to $3.9 million — more than any medicine in history, more than a 45-year supply of Humira, the autoimmune drug often held up as an emblem of America’s runaway drug spending.

It was a testament to the power of a new class of gene therapies to deliver something pharma so rarely does: Genuine cures. The treatment, approved last week as Lenmeldy, may allow some babies born with an ultra-rare neurodegenerative disease called metachromatic leukodystrophy, or MLD, to grow up and live essentially normal lives.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Ventyx halts psoriasis drug development after lackluster trial results

knowledge

entertainment

WSS

Cancer diagnosis changes perspective doctor, former hospital CEO

Cord blood banking comes at a high cost to babies

FDA's Pazdur wants cancer trials to range beyond China alone

Cord blood banking comes at a high cost to babies

Ultragenyx gene therapy for rare liver ailment succeeds in late

With trial win, GSK could get blood cancer drug back on market

focus

hotspot

explore

As demand for Covid shots wanes, Moderna seeks its next success

White House drug czar issues call for 'recovery

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

After decades in use, heart stents finally beat placebo

Wildfire smoke exposes gaps in outdoor worker protections

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Woman returns to dialysis after doctors remove transplanted pig kidney

DIEP, the 'gold standard' of breast reconstruction, is under threat

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

entertainment

Experimental asthma app from Apple and Anthem shows promise

Ohio still needs to do more to protect the right to abortion

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

UnitedHealth sued over use of algorithm in Medicare Advantage plans

With trial win, GSK could get blood cancer drug back on market

Innovation in antibiotics is ailing. 'Brain drain' may kill it

knowledge

hotspot

entertainment

leisure time